Erwin Carlin 's Entries

1 blog
  • 15 Aug 2018
    Our attorneys have filed a mass tort lawsuit on behalf of sufferers who took the blood thinner Xarelto (rivaroxaban) and suffered severe bleeding events. Pharmaceutical businesses, such as the makers of Xarelto, have a duty to ensure that their drugs are reasonably protected for use - and failure to do so could be grounds for compensation. Our lawyers are functioning tough to get these hurt by the drug the compensation they are entitled to.Whilst bleeding is actually a widespread complication associated with anticoagulants, it has been alleged that Xarelto is more unsafe than conventional blood thinners because no antidote exists to reverse its blood-thinning effects. This means that, within the occasion of an emergency, patients may possibly be at risk for irreversible bleeding troubles, which includes life-threatening internal and gastrointestinal hemorrhaging.In the event you or even a loved 1 suffered a serious bleeding event following taking Xarelto, you might have legal recourse. For a lot more info, contact us right now to possess your case reviewed, free of charge of charge.Compensation Possibilitiesxarelto-compensation-photoThe plaintiffs in these lawsuits are seeking compensation from Bayer and Janssen for previous and future medical bills, lost wages, pain and suffering and, in cases of death, funeral expenses. In addition, they are searching for punitive damages, which are typically awarded to punish the defendant and deter other organizations from acting similarly.Why Are Lawsuits Getting Filed?Bayer and Johnson & Johnson’s Janssen Pharmaceuticals, Inc. are facing several Xarelto lawsuits alleging that the drug is harmful and defective. The plaintiffs claim that, unlike traditional anticoagulants (e.g. warfarin, Coumadin) whose blood-thinning effects can be reversed using vitamin K, there is no antidote available for Xarelto. Because of this, the lawsuits claim, doctors have no effective means of stopping Xarelto users from bleeding inside the event of an emergency. Plaintiffs inside the lawsuits allege significant and fatal injuries, like cerebral hemorrhaging and gastrointestinal bleeds, from use of the drug.In addition to these risks, lawsuits against Bayer and Johnson & Johnson’s Janssen Pharmaceuticals are alleging:The manufacturers of Xarelto marketed the drug as a superior in the field of anticoagulants despite studies finding higher rates of gastrointestinal (GI tract) bleeding and transfusions in xarelto medicine users than users of certain competitors.The makers of the drug continue to market Xarelto as a secure anticoagulant option.Doctors and medical staff were not properly made aware of methods to stabilize and treat a Xarelto user within the event of a bleeding complication.Users of Xarelto were not adequately warned of the health risks of suffering a fatal bleeding event.Xarelto is linked to serious bleeding complications, excessive blood loss, intracranial hemorrhaging, eye bleeding (vitreous hemorrhage), stomach bleeding, gastrointestinal bleeding, wound infections from inhibited clotting, and lack of effectiveness in preventing dangerous clotting.Visit this page for a lot more information on the alleged health risks of Xarelto.Multidistrict Litigation Trial Dates SetThe attorneys within the Complex Litigation Group have filed lawsuits on behalf of injured clients. The claims will proceed through multidistrict litigation (MDL), which currently entails four trials, scheduled for Fall 2016, in which random groups of plaintiffs will be chosen to represent the group.
    187 Posted by Erwin Carlin
  • Our attorneys have filed a mass tort lawsuit on behalf of sufferers who took the blood thinner Xarelto (rivaroxaban) and suffered severe bleeding events. Pharmaceutical businesses, such as the makers of Xarelto, have a duty to ensure that their drugs are reasonably protected for use - and failure to do so could be grounds for compensation. Our lawyers are functioning tough to get these hurt by the drug the compensation they are entitled to.Whilst bleeding is actually a widespread complication associated with anticoagulants, it has been alleged that Xarelto is more unsafe than conventional blood thinners because no antidote exists to reverse its blood-thinning effects. This means that, within the occasion of an emergency, patients may possibly be at risk for irreversible bleeding troubles, which includes life-threatening internal and gastrointestinal hemorrhaging.In the event you or even a loved 1 suffered a serious bleeding event following taking Xarelto, you might have legal recourse. For a lot more info, contact us right now to possess your case reviewed, free of charge of charge.Compensation Possibilitiesxarelto-compensation-photoThe plaintiffs in these lawsuits are seeking compensation from Bayer and Janssen for previous and future medical bills, lost wages, pain and suffering and, in cases of death, funeral expenses. In addition, they are searching for punitive damages, which are typically awarded to punish the defendant and deter other organizations from acting similarly.Why Are Lawsuits Getting Filed?Bayer and Johnson & Johnson’s Janssen Pharmaceuticals, Inc. are facing several Xarelto lawsuits alleging that the drug is harmful and defective. The plaintiffs claim that, unlike traditional anticoagulants (e.g. warfarin, Coumadin) whose blood-thinning effects can be reversed using vitamin K, there is no antidote available for Xarelto. Because of this, the lawsuits claim, doctors have no effective means of stopping Xarelto users from bleeding inside the event of an emergency. Plaintiffs inside the lawsuits allege significant and fatal injuries, like cerebral hemorrhaging and gastrointestinal bleeds, from use of the drug.In addition to these risks, lawsuits against Bayer and Johnson & Johnson’s Janssen Pharmaceuticals are alleging:The manufacturers of Xarelto marketed the drug as a superior in the field of anticoagulants despite studies finding higher rates of gastrointestinal (GI tract) bleeding and transfusions in xarelto medicine users than users of certain competitors.The makers of the drug continue to market Xarelto as a secure anticoagulant option.Doctors and medical staff were not properly made aware of methods to stabilize and treat a Xarelto user within the event of a bleeding complication.Users of Xarelto were not adequately warned of the health risks of suffering a fatal bleeding event.Xarelto is linked to serious bleeding complications, excessive blood loss, intracranial hemorrhaging, eye bleeding (vitreous hemorrhage), stomach bleeding, gastrointestinal bleeding, wound infections from inhibited clotting, and lack of effectiveness in preventing dangerous clotting.Visit this page for a lot more information on the alleged health risks of Xarelto.Multidistrict Litigation Trial Dates SetThe attorneys within the Complex Litigation Group have filed lawsuits on behalf of injured clients. The claims will proceed through multidistrict litigation (MDL), which currently entails four trials, scheduled for Fall 2016, in which random groups of plaintiffs will be chosen to represent the group.
    Aug 15, 2018 187